Immunocytochemical study of interleukin-1β in alveolar macrophages of patients with well-controlled and non-controlled asthma

S. Pospelova, V. Kravtsov, S. Sobchenko, A. Parfionov (Saint Petersburg, Russian Federation)

Source: Annual Congress 2011 - Immunology and cell biology of asthma and COPD
Session: Immunology and cell biology of asthma and COPD
Session type: Thematic Poster Session
Number: 3844
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Pospelova, V. Kravtsov, S. Sobchenko, A. Parfionov (Saint Petersburg, Russian Federation). Immunocytochemical study of interleukin-1β in alveolar macrophages of patients with well-controlled and non-controlled asthma. Eur Respir J 2011; 38: Suppl. 55, 3844

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Radiologic assed rhinosinusitis, eosinophils and lung function in a population-based cohort of elderly, a comparison of subjects with and without asthma
Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases
Year: 2020

A single-center observational study assessing response to mepolizumab in severe eosinophilic asthma
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019

Characteristics of children with asthma and blood eosinophilia: an observational study
Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma
Year: 2021

Cilomilast reduces CD8+ T-lymphocytes and macrophages in patients with chronic obstructive pulmonary disease (COPD): a double-blind placebo-controlled, parallel-group quantitative study of bronchial biopsies
Source: Eur Respir J 2001; 18: Suppl. 33, 338s
Year: 2001

Neomacrolides in the treatment of patients with severe asthma and/or bronchiectasis: A retrospective observational study
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010


A retrospective observational study to characterize severe eosinophilic asthma in Taiwan
Source: International Congress 2018 – Asthma and allergy in adults and children and their biomarkers
Year: 2018




Heliox and alveolar oxygenation in patients with chronic obstructive pulmonary disease: a multicentre, randomised, crossover study
Source: Eur Respir J 2004; 24: Suppl. 48, 243s
Year: 2004

Development of asthma in patients with eosinophilic bronchitis: prospective follow up study
Source: Eur Respir J 2002; 20: Suppl. 38, 51s
Year: 2002

Cross-sectional, observational study to estimate the prevalence of the eosinophilic phenotype for Brazilian patients with severe asthma: the BRAEOS study
Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD
Year: 2020


A proof-of-concept randomized-controlled trial of omalizumab in patients with severe difficult to control nonatopic asthma
Source: Annual Congress 2012 - Clinical diagnosis and treatment of adult asthma
Year: 2012


The evaluation of the efficacy and safety of phospholipids‘ inhalation in patients with bronchial asthma (BA): A prospective randomized placebo-controlled study
Source: Annual Congress 2012 - Asthma treatment: efficacy and safety
Year: 2012

Clinical and inflammatory characteristics of patients with COPD in primary care: an observational study
Source: International Congress 2017 – Markers of COPD progression
Year: 2017

Observational study in severe asthmatic patients after discontinuation of omalizumab for good asthma control
Source: Annual Congress 2012 - Clinical diagnosis and treatment of adult asthma
Year: 2012


A pilot randomised clinical trial of mepolizumab in COPD with eosinophilic bronchitis
Source: Eur Respir J , 49 (3) 1602486; DOI: 10.1183/13993003.02486-2016
Year: 2017


Reslizumab for uncontrolled eosinophilic asthma in patients who experienced a single exacerbation in the previous year: sub-analysis of two phase 3 trials
Source: International Congress 2017 – Asthma management
Year: 2017


Prospective case-control study describing the lower airway microbiome in pre-school children with cystic fibrosis
Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments
Year: 2018



The infiltration of inflammatory cells in the apparently normal bronchial mucosa in anthracotic patients after discontinuation of exposure to fossil fuel: a prospective study
Source: Virtual Congress 2020 – Air pollution as a cause of respiratory disease
Year: 2020


Pharmacological effect of lysozyme for COPD and bronchial asthma with sputum: A randomized, placebo-controlled, cross-over study
Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs
Year: 2014


A multicentre, observational cohort study to determine the efficacy and safety of lumacaftor/ivacaftor in patients with severe lung disease and cystic fibrosis
Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis
Year: 2019



Characteristics of asthma patients with frequent exacerbations – an observational study in Sweden
Source: International Congress 2017 – Primary care management of asthma and self-management of respiratory disease
Year: 2017